These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28656603)

  • 1. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
    Na R; Helfand BT; Chen H; Conran CA; Crawford SE; Hayward SW; Tammela TLJ; Hoffman-Bolton J; Zheng SL; Walsh PC; Schleutker J; Platz EA; Isaacs WB; Xu J
    Prostate; 2017 Aug; 77(11):1213-1220. PubMed ID: 28656603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.
    Cartwright R; Mangera A; Tikkinen KA; Rajan P; Pesonen J; Kirby AC; Thiagamoorthy G; Ambrose C; Gonzalez-Maffe J; Bennett PR; Palmer T; Walley A; Järvelin MR; Khullar V; Chapple C
    Eur Urol; 2014 Oct; 66(4):752-68. PubMed ID: 24491308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.
    Gudmundsson J; Sigurdsson JK; Stefansdottir L; Agnarsson BA; Isaksson HJ; Stefansson OA; Gudjonsson SA; Gudbjartsson DF; Masson G; Frigge ML; Stacey SN; Sulem P; Halldorsson GH; Tragante V; Holm H; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Jonsson T; Jonsson E; Barkardottir RB; Hilmarsson R; Asselbergs FW; Geirsson G; Thorsteinsdottir U; Rafnar T; Thorleifsson G; Stefansson K
    Nat Commun; 2018 Nov; 9(1):4568. PubMed ID: 30410027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.
    Egan KB; Suh M; Rosen RC; Burnett AL; Ni X; Wong DG; McVary KT
    Int J Clin Pract; 2015 Nov; 69(11):1316-25. PubMed ID: 26215544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms.
    Lee YC; Wu WJ; Liu CC; Wang CJ; Li WM; Huang CH; Yeh HC; Ke HL; Huang SP
    J Sex Med; 2009 Nov; 6(11):3158-65. PubMed ID: 19515207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with responsiveness to a selective α1 -blocker in men with benign prostatic hyperplasia related lower urinary tract symptoms.
    Lee YC; Juan YS; Liu CC; Bao BY; Wang CJ; Wu WJ; Huang CN; Huang SP
    BJU Int; 2016 Aug; 118(2):313-9. PubMed ID: 26940040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin Use and Lower Urinary Tract Symptoms Incidence and Progression in Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial.
    Kramer JJ; Gu L; Moreira D; Andriole G; Csizmadi I; Freedland SJ
    J Urol; 2022 Feb; 207(2):417-423. PubMed ID: 34544265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive males have higher odds of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a retrospective cohort study based on propensity score matching.
    Xiong Y; Zhang YC; Jin T; Qin F; Yuan JH
    Asian J Androl; 2021; 23(6):633-639. PubMed ID: 33818525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
    Speakman M; Kirby R; Doyle S; Ioannou C
    BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.
    Helfand BT; Hu Q; Loeb S; McVary KT; Catalona WJ
    J Urol; 2013 Mar; 189(3):845-8. PubMed ID: 23159463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas.
    Yue L; Wang T; Ge Y; Ge M; Zhang C; Hou Q; Wang W; Tian H; Ren B; Du B; Zhang W
    Prostate; 2019 Feb; 79(3):312-319. PubMed ID: 30450670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis.
    Gacci M; Corona G; Sebastianelli A; Serni S; De Nunzio C; Maggi M; Vignozzi L; Novara G; McVary KT; Kaplan SA; Gravas S; Chapple C
    Eur Urol; 2016 Nov; 70(5):788-796. PubMed ID: 27451136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.